CRON

Cronos Group Inc.

Price

$3.23

return (12m)

28.49%

p/e

17.22

p/bv

1.08

DIVIDEND YIELD

0.00%

CRON price

Cronos Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CRON

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.20%

3 months

17.49%

1 year

28.49%

2 years

52.84%

5 years

-39.94%

10 years

252.46%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CRON

Valuation

P/E

17.22

Sector 1.05

Industry -1.68

P/BV

1.08

Sector 1.86

Industry 1.29

P/Revenue (PSR)

6.73

Sector 1.54

Industry 2.16

EV/EBITDA

37.15

Sector -46.28

Industry -37.41

EV/EBIT

53.64

Sector -48.92

Industry -41.08

P/EBITDA

133.65

Sector -31.58

Industry -22.94

P/EBIT

-228.42

Sector -43.50

Industry -27.05

P/Total Assets

1.02

Sector 0.85

Industry 0.74

P/Net Current Assets

1.42

Sector -25.69

Industry -67.97

P/Working Capital

1.41

Sector -3.90

Industry -1.86

EPS

0.19

Sector -0.70

Industry -1.21

BVPS

2.99

Sector 4.52

Industry 2.81

Efficiency

Gross Margin

45.86%

Sector 49.51%

Industry 50.48%

EBITDA Margin

20.71%

Sector -280.81%

Industry -17,123,193.33%

EBIT Margin

14.35%

Sector -163.94%

Industry -17,075,660.18%

Operating Margin

-1.36%

Sector -19.82%

Industry -25.75%

Net Profit Margins

39.08%

Sector -24.01%

Industry -27.84%

Asset Turnover

0.04

Sector 0.13

Industry 0.06

Profitability

ROE

6.26%

Sector -23.78%

Industry -36.79%

ROA

5.93%

Sector -24.20%

Industry -47.72%

ROIC

9.57%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

16.18

Sector 1.91

Industry 2.51

Net Debt / EBITDA

-72.60

Sector -23.21

Industry -8.98

Net Debt / EBIT

-104.82

Sector -17.93

Industry -37.38

Net Debt / Equity

-0.71

Sector -0.68

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.56

Equity/Assets

0.95

Sector 0.46

Industry 0.52

Liabilities/Assets

0.05

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

22.64%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CRON

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Cronos Group ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$3.23

Fair Value

$3.58

Upside

10.86%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CRON Cronos Group Inc.	$3.23	20.34%	0.00%	17.22	1.08	6.26%	39.08%
LLY Eli Lilly and Compay	$1,172.61	39.53%	0.57%	39.18	30.89	78.84%	33.53%
SNY Sanofi	$40.11	-14.58%	4.41%	3.76	0.69	18.43%	14.25%
GSK GlaxoSmithKline PLC	$46.46	10.87%	3.82%	14.42	4.07	28.24%	14.54%
CRMD CorMedix Inc.	$7.40	-34.34%	0.00%	3.10	1.26	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$26.28	1.14%	0.00%	14.60	1.49	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.45	-10.37%	0.67%	28.25	2.55	9.03%	10.14%
JNJ Johnson & Johnson	$260.17	40.26%	2.03%	29.77	7.37	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$422.48	-5.72%	0.00%	47.67	8.18	17.15%	28.44%
NVS Novartis AG	$143.40	10.49%	2.16%	21.42	6.51	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$658.55	23.35%	0.27%	35.04	4.63	13.22%	15.04%
ABT Abbott Laboratories	$99.62	-23.07%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$87.72	-6.71%	3.28%	21.29	2.19	10.29%	13.93%
CVS CVS Health Corporation	$87.23	17.87%	3.07%	22.64	1.39	6.12%	1.18%
BSX Boston Scientific Corp.	$42.17	-56.44%	0.00%	17.05	2.51	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.00	-31.41%	0.00%	18.01	5.27	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$518.98	-17.61%	0.00%	35.95	25.41	70.67%	25.03%
RMD ResMed Inc.	$229.57	-17.84%	1.07%	21.81	5.05	23.13%	26.94%
HCA HCA Healthcare Inc.	$447.24	5.42%	0.68%	14.42	-30.74	-213.15%	8.77%
COHR Coherent Inc.	$307.35	163.43%	0.00%	74.48	5.34	7.16%	11.31%
DHR Danaher Corporation	$219.22	8.19%	0.66%	38.55	2.93	7.61%	15.95%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CRON - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Cronos Group

Cronos Group Inc.

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2016

Time since IPO - 10 years

665

Employees

Cronos Group Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.20 billion, with shareholders equity totaling $1.12 billion.

The company employs approximately 665 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Cronos Group Inc. reported $179.09 million in revenue, generating net income of $69.98 million.

Key financial metrics include a P/E ratio of 17.22, a price-to-book (P/B) ratio of 1.08, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRON.

Market cap

$1.20 billion

Net worth

$1.12 billion

$1,117,445,000.00

Assets

$1.18 billion

$1,179,860,000.00

Total Shares Outstanding

373.61 million

373,609,000

Average Daily Trading Volume

$1.22 million

$1,218,978.00

Sector

Health

Industry

Pharmaceutical Products

CRON

CRON revenue and profits

Financial Results CRON

DRAG THE FRAME TO SEE MORE DATA

CRON cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.23 15,51% (12M)

P/E

22.64

3.07%

ROE

6.12%

P/BV

1.39

CI - Cigna

$282.51 --3,94% (12M)

P/E

10.91

2.19%

ROE

16.04%

P/BV

1.75

CNC - Centene

$65.98 84,51% (12M)

P/E

-6.39

0.00%

ROE

-22.53%

P/BV

1.44

HUM - Humana

$436.13 57,89% (12M)

P/E

40.85

0.81%

ROE

6.63%

P/BV

2.71

SNY - Sanofi

$40.11 --13,32% (12M)

P/E

3.76

4.41%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$260.17 39,50% (12M)

P/E

29.77

2.03%

ROE

24.76%

P/BV

7.37

LLY - Eli Lilly

$1,172.61 41,58% (12M)

P/E

39.18

0.57%

ROE

78.84%

P/BV

30.89

HCA - HCA Healthcare

$447.24 8,25% (12M)

P/E

14.42

0.68%

ROE

-213.15%

P/BV

-30.74